Novanta Inc. to Acquire Riverpoint Medical
June 9, 2026
Novanta Inc. entered into a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion upfront cash plus a $250 million milestone payment in Q1 2027. The transaction is expected to close in Q3 2026, subject to regulatory approvals and customary closing conditions.
- Buyers
- Novanta Inc.
- Targets
- Riverpoint Medical
- Sellers
- Arlington Capital Partners
- Industry
- Medical Devices
- Location
- Oregon, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.